Talecris Biotherapeutics Holdings Corp. Watch

from 8-K 18 pages First Amendment to Revolving Credit Agreement

from S-1/A 5 pages Ampersand Ventures, Through One or More of Its Affiliated Funds and Managed Accounts (“Ampersand”), Directly or Indirectly Owns 25.7% of the Outstanding Membership Interests in Talecris Plasma Holdings, LLC (“Holdings”), Which in Turn Owns a Controlling Interest in Talecris Biotherapeutics Holdings Corp. (The “Company”). the Company Is One of the Borrowers Under the First Lien Term Loan, Second Lien Term Loan and Revolving Credit Agreements Dated December 6, 2006 (Together the “Credit Agreements”). Capitalized Terms Used but Not Defined Herein Shall Have the Meanings Set Forth in the Credit Agreements

from S-1/A 5 pages Cerberus Capital Management, L.P., Through One or More of Its Affiliated Funds and Managed Accounts (“Cerberus”), Directly or Indirectly Owns 74.3% of the Outstanding Membership Interests in Talecris Plasma Holdings, LLC (“Holdings”), Which in Turn Owns a Controlling Interest in Talecris Biotherapeutics Holdings Corp. (The “Company”). the Company Is One of the Borrowers Under the First Lien Term Loan, Second Lien Term Loan and Revolving Credit Agreements Dated December 6, 2006 (Together the “Credit Agreements”). Capitalized Terms Used but Not Defined Herein Shall Have the Meanings Set Forth in the Credit Agreements

from S-1/A 120 pages Revolving Credit Agreement Dated as of December 6, 2006 Among Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics, Inc. Precision Pharma Services, Inc. and Talecris Plasma Resources, Inc. as Borrowers, the Lenders Party Hereto, Wachovia Bank, National Association as Administrative Agent, Morgan Stanley Senior Funding, Inc. as Syndication Agent, Goldman Sachs Credit Partners L.P. as Co-Documentation Agent, Ge Capital Corporation, as Co-Documentation Agent, and Wells Fargo Foothill, Inc. as Collateral Agent and Co-Documentation Agent Morgan Stanley Senior Funding, Inc. and Goldman Sachs Credit Partners L.P. as Joint Lead Arrangers and Joint Bookrunners

from S-1/A 91 pages Second Lien Term Loan Credit Agreement Dated as of December 6, 2006 Among Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics, Inc. Precision Pharma Services, Inc. and Talecris Plasma Resources, Inc. as Borrowers, the Lenders Party Hereto, Morgan Stanley Senior Funding, Inc. as Administrative Agent and Syndication Agent and Goldman Sachs Credit Partners L.P. as Documentation Agent Morgan Stanley Senior Funding, Inc. and Goldman Sachs Credit Partners L.P. as Joint Lead Arrangers and Joint Bookrunners

from S-1/A 91 pages First Lien Term Loan Credit Agreement Dated as of December 6, 2006 Among Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics, Inc. Precision Pharma Services, Inc. and Talecris Plasma Resources, Inc. as Borrowers, the Lenders Party Hereto, Morgan Stanley Senior Funding, Inc. as Administrative Agent and Syndication Agent and Goldman Sachs Credit Partners L.P. as Documentation Agent Morgan Stanley Senior Funding, Inc. and Goldman Sachs Credit Partners L.P. as Joint Lead Arrangers and Joint Bookrunners